Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:chemical_compound
|
| gptkbp:bfsLayer |
4
|
| gptkbp:bfsParent |
gptkb:Anaxyrus_boreas
|
| gptkbp:composed_of |
gptkb:charity
|
| gptkbp:developed_by |
gptkb:toads
|
| gptkbp:has_impact_on |
hallucinogenic effects
|
| https://www.w3.org/2000/01/rdf-schema#label |
bufotenin
|
| gptkbp:ingredients |
C12 H16 N2 O
|
| gptkbp:is_found_in |
gptkb:Bufo_alvarius
|
| gptkbp:is_related_to |
serotonin
|
| gptkbp:is_used_in |
gptkb:product
|
| gptkbp:legal_issue |
varies by country
|
| gptkbp:previous_name |
N, N-Dimethyl-5-hydroxytryptamine
|